Helicobacter pylori infection and the risk of gastric carcinoma

New England Journal of Medicine

Volumn 325, Issue 16, 1991, Pages 1127-1131

  Parsonnet, Julie ^a   Friedman, Gary D ^b   Vandersteen, Daniel P ^a   Chang, Yuan ^a   Vogelman, Joseph H ^c   Orentreich, Norman ^c   Sibley, Richard K ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DIVISION OF RESEARCH   (United States)

^c Orentreich Foundation for the Advancement of Science Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM ANTIBODY; IMMUNOGLOBULIN G ANTIBODY;

ADENOCARCINOMA; ADULT; ARTICLE; ATROPHIC GASTRITIS; BACTERIAL INFECTION; CARCINOGENESIS; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HELICOBACTER PYLORI; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; RISK FACTOR; STOMACH CARCINOMA;

ADENOCARCINOMA; AGED; ANTIBODIES, BACTERIAL; BLOOD GROUPS; CARDIA; ESOPHAGOGASTRIC JUNCTION; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMAN; IMMUNOGLOBULIN G; MALE; MIDDLE AGE; PEPTIC ULCER; POSTOPERATIVE COMPLICATIONS; RACIAL STOCKS; RISK; SEX FACTORS; SMOKING; STOMACH; STOMACH NEOPLASMS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TIME FACTORS;

EID: 0025945933     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM199110173251603     Document Type: Article

References (41)

1. Parkin DM, Laara E, Muir CS. Estimates of the worldwide frequency of sixteen major cancers in 1980. Int J Cancer 1988; 41: 184–97.
2. Howson CP, Hiyama T, Wynder EL. The decline in gastric cancer; epidemiology of an unplanned triumph. Epidemiol Rev 1986; 8: 1–27.
3. Parkin DM. Cancer occurrence in developing countries. Lyon, France: International Agency for Research on Cancer, 1986. (IARC scientific publications no. 75.)
4. Muir C, Waterhouse J, Mack T, Powell J, Whelan S, eds. Cancer incidence in five continents. Vol. 5. Lyon, France: International Agency for Research on Cancer, 1987. (IARC scientific publications no. 88.)
5. Correa P, Haenszel W. Epidemiology of gastric cancer. In: Correa P, Haenszel W, eds. Epidemiology of cancer of the digestive tract. The Hague, the Netherlands: Martinus Nijhoff, 1982:58–84.
6. Correa P, Cuello C, Duque E. Carcinoma and intestinal metaplasia of the stomach in Colombian migrants. J Natl Cancer Inst 1970; 44: 297–306.
7. Haenszel W, Kurihara M, Segi M, Lee RKC. Stomach cancer among Japanese in Hawaii. J Natl Cancer Inst 1972; 49: 969–88.
8. Armijo R, Orellana M, Medina E, Coulson AH, Sayre JW, Detels R. Epidemiology of gastric cancer in Chile. I — case–control study. Int J Epidemiol 1981; 10: 53–6.
9. Munoz N, Correa P, Cuello C, Duque E. Histologic types of gastric cancer in high- and low-risk areas. Int J Cancer 1968; 3: 809–18.
10. Munoz N, Connelly R. Time trends of intestinal and diffuse types of gastric cancer in the United States. Int J Cancer 1971; 81: 58–64.
11. Sipponen P, Jarvi O, Kekki M, Siurala M. Decreased incidences of intestinal and diffuse types of gastric cancer in Finland during a 20-year period. Scand J Gastroenterol 1987; 22: 865–71.
12. Goodwin CS, Armstrong JA, Chilvers T, et al. Transfer of Campylobacter pylori and Campylobacter mustelae to Helicobacter gen. nov. as Helicobacter pylori comb. nov. and Helicobacter mustelae comb, nov., respectively. Int J Syst Bacteriol 1989; 39: 397–405.
13. Forman D, Sitas F, Newell DG, et al. Geographic association of Helicobacter pylori antibody prevalence and gastric cancer mortality in rural China. Int J Cancer 1990; 46: 608–11.
14. Fox JG, Correa P, Taylor NS, et al. Campylobacter pylori-associated gastritis and immune response in a population at increased risk of gastric carcinoma. Am J Gastroenterol 1989; 84: 775–81.
15. Jaskiewicz K, Louwrens HD, Woodroof CW, van Wyk MJ, Price SK. The association of Campylobacter pylori with mucosal pathological changes in a population at risk for gastric cancer. S Afr Med J 1989; 75: 417–9.
16. Talley NJ, Zinsmeister AR, DiMagno EP, et al. Gastric adenocarcinoma and Helicobacter pylori infection. J Natl Cancer Inst (in press).
17. Scott N, Lansdown M, Diament R, et al. Helicobacter gastritis and intestinal metaplasia in a gastric cancer family. Lancet 1990; 335: 728.
18. Correa P, Haenszel W, Cuello C, et al. Gastric precancerous process in a high risk population: cohort follow-up. Cancer Res 1990; 50: 4737–40.
19. Correa P, Cuello C, Duque E, et al. Gastric cancer in Colombia. III. Natural history of precursor lesions. J Natl Cancer Inst 1976; 57: 1027–35.
20. Parsonnet J, Vandersteen D, Goates J, Sibley RK, Pritikin J, Chang Y. Helicobacter pylori in intestinal- and diffuse-type gastric adenocarcinomas. J Natl Cancer Inst 1991; 83: 640–3.
21. Goodwin CS, Blincow E. Peterson G, et al. Enzyme-linked immunosorbent assay for Campylobacter pyloridis: correlation with presence of C pyloridis in the gastric mucosa. J Infect Dis 1987; 155: 488–94.
22. Hirschl AM, Pletschette M, Hirschl MH, Berger J, Stanek G, Rotter ML. Comparison of different antigen preparations in an evaluation of the immune response to Campylobacter pylori. Eur J Clin Microbiol Infect Dis 1988; 7: 570–5.
23. Perez-Perez GI, Dworkin BM, Chodos JE, Blaser MJ. Campylobacter pylori antibodies in humans. Ann Intern Med 1988; 109: 11–7.
24. Perez-Perez GI, Taylor DN, Bodhidatta L, et al. Seroprevalence of Helicobacter pylori infections in Thailand. J Infect Dis 1990; 161: 1237–41.
25. Faulde M, Putzker M, Mertes T, Sobe D. Evaluation of an immunofluorescence assay for specific detection of immunoglobulin G antibodies directed against Helicobacter pylori and antigenic cross-reactivity between H. pylori and Campylobacter jejuni. J Clin Microbiol 1991; 29: 323–7.
26. Morris A, Ali MR, Brown P, Lane M, Patton K. Campylobacter pylori infection in biopsy specimens of gastric antrum: laboratory diagnosis and estimation of sampling error. J Clin Pathol 1989; 42: 727–32.
27. Strauss RM, Wang TC, Kelsey PB, et al. Association of Campylobacter pylori infection with dyspeptic symptoms in patients undergoing gastroduodenoscopy. Am J Med 1990; 89: 464–9.
28. Collen JF, Davis LF. The multitest laboratory in health care. J Occup Med 1969; 11: 355–60.
29. Friedman GD, Blaner WS, Goodman DS, et al. Serum retinol and retinol-binding protein levels do not predict subsequent lung cancer. Am J Epidemiol 1986; 123: 781–9.
30. Friedman GD, Siegelaub AB, Seizcr CC. Cigarettes, alcohol, coffee and peptic ulcer. N Engl J Med 1974; 290: 469–73.
31. Evans DJ, Evans DG, Graham DY, Klein PD. A sensitive and specific serologic test for detection of Campylobacter pylori infection. Gastroenterology 1989; 96: 1004–8.
32. Garewal HS, Sampliner R. Barrett's esophagus: a model premalignant lesion for adenocarcinoma. Prev Med 1989; 18: 749–56.
33. Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. Acta Pathol Microbiol Scand 1965; 64: 31–49.
34. Robins J, Greenland S, Breslow NE. A general estimator for the variance of the MantelHaenszel odds ratio. Am J Epidemiol 1986; 124: 719–23.
35. Loffeld RJLF, Willems I, Flendrig JA, Arends JW. Helicobacter pylori and gastric carcinoma. Histopathology 1990; 17: 537–41.
36. Ames BN, Gold LS. Too many rodent carcinogens: mitogenesis increases mutagenesis. Science 1990; 249: 970–1.
37. Parsonnet J. The epidemiology of C. pylori. In: Blaser MJ, ed. Campylobacter pylori in gastritis and peptic ulcer disease. New York: Igaku-Shoin, 1989:51–60.
38. Rauws EAJ, Tytgat GNJ. Natural history of C. pylori infection. In: Blaser M, ed. Campylobacter pylori in gastritis and peptic ulcer disease. New York: Igaku-Shoin, 1989:187–93.
39. Buiatti E, Palli D, Decarli A, et al. A case–control study of gastric cancer and diet in Italy. II. Association with nutrients. Int J Cancer 1990; 45: 896–901.
40. Correa P, Cuello C, Fajardo LF, Haenszel W, Bolanos O, de Ramirez B. Diet and gastric cancer: nutrition survey in a high-risk area. J Natl Cancer Inst 1983; 70: 673–8.
41. Correa P. Clinical implications of recent developments in gastric cancer pathology and epidemiology. Semin Oncol 1985; 12: 2–10.